HC Wainwright reiterated their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has a $75.00 price objective on the stock. CGON has been the topic of a number of other research reports. The Goldman Sachs Group raised shares […]
CG Oncology (NASDAQ:CGON) Shares Gap Down to $34.29 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
CG Oncology (NASDAQ:CGON – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $75.00 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 131.48% from the […]
CG Oncology, Inc. to Present Positive Final Results from Phase 2 Core-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC At Asco 2024 Annual Meeting marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.